AusBiotech Investment

AusBiotech Investment is the national platform for investor readiness, capital engagement and capital formation across Australia’s life sciences sector.

As Australia’s leading life sciences industry body, AusBiotech is uniquely positioned to connect science, capability and capital through year-round programs, curated engagement and market-facing activity.

Built on more than 40 years of sector leadership, AusBiotech Investment is designed to strengthen the conditions for long-term investment by improving company readiness, increasing the visibility of high-quality opportunities, and supporting more effective capital conversations.

Where science, capability and capital connect

Australia produces world-class life sciences research, but scientific excellence alone does not create investable companies.

Capital formation depends on a broader set of conditions: commercial discipline, investor readiness, strategic visibility and access to the right capital at the right stage.

AusBiotech Investment exists to strengthen these conditions. Through an always-on model, it supports both companies and investors with more structured pathways to engagement, helping build a stronger pipeline of investment opportunities across the Australian life sciences ecosystem.

Our focus
• Investor readiness
• Company visibility
• Investor engagement
• Capital formation

AusBiotech Investment Programs

The Investment Readiness Panel (IRP)

The IRP supports Australian life sciences companies to better prepare for investor engagement and future capital raising.

Through structured, stage-relative feedback and investor-informed assessment, the IRP helps companies strengthen their investment proposition, sharpen their commercial and capital narrative, and better understand what sophisticated investors look for at each stage of growth.

Apply here →

AusBiotech Invest

AusBiotech Invest (October 20, 2026, Gold Coast) is for active, sophisticated investors and designed to strengthen the capital environment for the Australian life science sector.

The program is focused on building investor confidence, domestic syndication, global capital attraction and more co-ordinated pathways to fund high-potential Australian companies.
Registration is through an EOI and will be limited to venture capital investors; family offices; institutional investors; private investment groups; corporate venture and strategic investors; relevant capital market participants.

Express interest in attending here →

Our always-on approach

AusBiotech Investment is designed to support capital formation across the company lifecycle, not only at discrete event moments.

Its year-round activity includes investor readiness support, capital conversations, targeted introductions, investor briefings, one-to-one partnering and flagship engagement points such as AusBiotech Invest.
This integrated model helps improve both company preparedness and the broader investment profile of Australian life sciences, creating stronger foundations for sustained investor engagement over time.